|
Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis |
De Wals P, Coudeville L, Trottier P, Chevat C, Erickson L J, Nguyen V H |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details De Wals P, Coudeville L, Trottier P, Chevat C, Erickson L J, Nguyen V H. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. Vaccine 2007; 25(29): 5433-5440 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Aged; Aged, 80 and over; Canada /epidemiology; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Immunization, Secondary /economics; Infant; Meningococcal Infections /economics /epidemiology /prevention & Meningococcal Vaccines /economics; Middle Aged; control AccessionNumber 22007001460 Date bibliographic record published 27/07/2007 |
|
|
|